Table 1.
Clinical factor (%) | Blood (N=40) | Urine (N=40) | P |
---|---|---|---|
Age, median (IQR) | 72.5 (59–81) | 70 (54.5–78.5) | 0.473 |
Male sex, N (%) | 4 (10.0) | 2 (5.0) | 0.675 |
Time lag between fever or UTI symptom onset and bacterial culture sampling, days, median (IQR) | 2 (1–3.75) | 1 (0–4) | 0.382 |
History of antibiotic use within three days prior to bacterial culture sampling | 8/39 (20.5) | 7 (17.5) | 0.733 |
Antimicrobial use concordant with the antimicrobial susceptibility of the causative organisms | 3/39 (7.7) | 1 (2.5) | 0.359 |
Existence of any underlying urinary tract abnormalities | 18 (45.0) | 17 (42.5) | 0.822 |
Benign prostatic hypertrophy among male patients | 1/4 (25.0) | 2/2 (100) | 0.400 |
Neurogenic bladder | 1 (2.5) | 2 (5.0) | 1.000 |
Urolithiasis | 12 (30.0) | 5 (12.5) | 0.056 |
Urinary retention | 0 (0) | 1 (2.5) | 1.000 |
Vesicoureteral reflux | 0 (0) | 0 (0) | - |
Bladder diverticulum | 0 (0) | 1 (2.5) | 1.000 |
Prolapse of vagina among female patients | 0 (0) | 0 (0) | - |
Intubated urinary tract at the time of culture sampling | 5 (12.5) | 9 (22.5) | 0.239 |
Intermittent catheterization | 0 (0) | 2 (5.0) | 0.494 |
History of urinary catheterization during one month prior to inclusion | 4 (10.0) | 3 (7.5) | 1.000 |
Polycystic kidney | 0 (0) | 0 (0) | - |
Kidney tumor | 0 (0) | 1 (2.5) | 1.000 |
Urinary tract surgery during three months prior to inclusion | 2 (5.0) | 1 (2.5) | 1.000 |
Surgically reconstructed bladder | 0 (0) | 0 (0) | - |
Abbreviations: IQR, interquartile range; UTI, urinary tract infection.